Download now to build your daily schedules, review abstracts, take notes and much more.
The Alzheimer's Association is proud to celebrate the individuals who have made significant contributions to further the vision of a world without Alzheimer's disease.
On This Page:
AAIC provides the Alzheimer's Association with the opportunity to present awards to some of the most prominent leaders in the field. These prestigious awards recognize the work of distinguished Alzheimer's researchers, as well as those who are just beginning their career in this vital field.
The AAIC Lifetime Achievement Awards recognize a senior investigator whose contributions, whether they have been in research, leadership or mentorship, have shown a lasting impact on the field and whose body of work has demonstrated a lifetime commitment towards progress against Alzheimer's and dementia.
The awards are named in honor of Henry Wisniewski, M.D., Ph.D.; Khalid Iqbal, Ph.D.; and Bengt Winblad, M.D., Ph.D.—co-founders of the Alzheimer's Association scientific conference, now known as the Alzheimer's Association International Conference (AAIC). Since its inception and first iteration they each held key leadership roles in planning and conceptualizing the conference:
2019 award recipients:
Dr. Albert is the recipient of the Henry Wisniewski Lifetime Achievement Award in Alzheimer’s Disease Research. She is the Director of the Division of Cognitive Neuroscience in the Department of Neurology at Johns Hopkins Hospital and the Director of the Johns Hopkins Alzheimer’s Disease Research Center. Dr. Albert’s work has identified cognitive changes that occur with aging and early Alzheimer’s, as well as lifestyle factors that may preserve cognitive abilities during aging. Her research currently focuses on early identification of Alzheimer’s and potential methods to monitor disease progression for early intervention.
Dr. de Leon is the recipient of the Bengt Winblad Lifetime Achievement Award in Alzheimer’s Disease Research. He is the founder and director of the Center for Brain Health in NYU Langone’s Department of Psychiatry. Dr. de Leon published some of the first studies showing early hippocampal atrophy and glucose metabolism alterations in Alzheimer’s disease, as well as the first longitudinal imaging reports to predict the transition from normal aging to Alzheimer’s. His work specializes in identifying biological markers for detecting Alzheimer’s.
Dr. Lannfelt is the recipient of the Khalid Iqbal Lifetime Achievement Award in Alzheimer’s Disease Research. He is a Senior Professor of Geriatrics in the Department of Public Health and Caring Services at Uppsala University where his research focuses on the pathological changes that occur in the brain with Alzheimer’s. Dr. Lannfelt led development of the Alzheimer’s drug candidate BAN2401, a monoclonal antibody that selectively binds to and neutralizes amyloid beta aggregates thought to contribute to Alzheimer’s neurodegeneration and which is currently being evaluated in a global Phase 3 study. For this work, he received the 2019 Swedish Alzheimer’s Foundation Grand Research Prize.
The Jerome H. Stone Philanthropy Award for Alzheimer's Research honors the legacy of Mr. Jerome Stone, a visionary who was among the first to call for investment in Alzheimer's research. Inspired by the loving memory of his late wife, Evelyn T. Stone, he took the helm of the Alzheimer's movement as the primary founder of the Alzheimer's Association.
Mr. Stone was renowned for his leadership, determination and generosity in the fight against Alzheimer’s, and for his support of research in particular. For many years, he served as the honorary chair of the Alzheimer's Association National Board of Directors. Mr. Stone passed away on January 1, 2015 at the age of 101.
This award, given in his name, honors the world's top philanthropists for advancing scientific progress toward treatment and prevention of Alzheimer's disease through their generous commitment to research.
2019 award recipients:
Dagmar Dolby and David Dolby are the recipients of the Jerome H. Stone Philanthropy Award for their philanthropic contributions toward the advancement of Alzheimer’s research, which they make to honor the memory and legacy of sound pioneer Ray Dolby, who passed away with the disease in 2013.
Dagmar is president and David is chief financial officer of the Ray and Dagmar Dolby Family Fund, which helped to found the Dolby Family Center for Mood Disorders at the University of California San Francisco. As philanthropists, the Dolby family has advanced dementia science through their support of the Alzheimer’s Association International Research Grant Program and its Part the Cloud competitions, as well as other academic and nonprofit institutions. They have been a member of the Alzheimer’s Association Zenith Society since 2012.
The Inge Grundke-Iqbal Award for Alzheimer's Research is presented to the senior author of the most impactful study published in Alzheimer's research over the preceding two years (January 1, 2017 – December 31, 2018).
Only members from the International Society to Advance Alzheimer’s Research and Treatment (ISTAART) may nominate candidates.
About Dr. Inge Grundke-Iqbal
Inge Grundke-Iqbal served as Professor and Head of Neuroimmunology at the New York State Institute for Basic Research in Developmental Disabilities from 1977 until her passing in September 2012. She was a world renowned neuroscientist and Alzheimer disease researcher. She was author/co-author of over 250 scientific publications in prestigious American and international journals and books. Dr. Grundke-Iqbal made several seminal discoveries in the biology of Alzheimer's disease and related conditions. Her discovery of the abnormal hyperphosphorylation of tau opened a whole new area of research in neurodegeneration, especially Alzheimer's disease and related tauopathies. Her research contributions won her several U.S. Public Health Service, National Institutes of Health and non-federal research grants and honors. Dr. Grundke-Iqbal served as a member of the International Scientific Advisory Committee of the International Conference on Alzheimer's Disease and Related Disorders (now known as the Alzheimer's Association International Conference).
The de Leon Prizes in Neuroimaging recognize a senior scientist and a new investigator (first authors) who are judged to have each published the best paper in any peer-reviewed journal related to the topic of in-vivo neuroimaging of a neurodegenerative process. Members of the ISTAART Neuroimaging Professional Interest Area (NPIA) are the nominating body for the two awards.
2019 award recipients:
Liana G. Apostolova, M.D., a Barbara and Peer Baekgaard Professor of Alzheimer’s Disease Research at Indiana University School of Medicine, is the de Leon Prize recipient in the Senior Scientist Category for her paper titled “Associations of the Top 20 Alzheimer Disease Risk Variants with Brain Amyloidosis.” Apostolova’s study provides a large, comprehensive look at how different Alzheimer’s risk genes affect amyloid deposition in the brain.
Brian A. Gordon, Ph.D., an Instructor in the Department of Radiology at Washington University School of Medicine, is the de Leon Prize recipient in the New Investigator Category for his paper titled “Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.” The study presents some of the most reliable evidence to date for biological markers of Alzheimer’s disease more than 20 years before dementia onset.
Using review scores as a guide, the AIC Chairs judge and select the best oral and poster presentations presented during AIC. The 2019 recipients will be announced onsite during AIC 2019.
Competitions are held in each conference program theme to determine the best posters by students and post-docs at AAIC. Judging will take place onsite by the Scientific Program Committee and invited guest judges. The competition is based on the four programmatic themes of AAIC: Basic and Translational Science, Diagnosis and Prognosis, Public Health and Psychosocial, and Therapeutics. Students and post-docs may submit their interest in the poster competition during abstract submission.